Position
Essential Partners LLC in Vaxcyte, Inc.
Back to the book · All holders of PCVX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $59$46.20 → $58.10
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q3 2025 | 2 | $72 | — | — | — | 0.0% |
| Q4 2025 | 5 | $231 | $46.20 | $20 | $139 | 0.0% |
| Q1 2026 | 21 | $1.22K | $58.10 | $59 | $930 | 0.0% |